Stryker Corporation

SYK Healthcare Medical Devices

Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024.

Revenue
+7.64%
EPS
−12.4%
Free cash flow
−19.4%
Total debt
−10.0%

Quarter to September 2026, against a year earlier

324.26 10.82 −3.23%
Market cap
$127.6B
P/E
35.3×
Fwd P/E
24.6×
Dividend yield
1.05%
F-score
5/9
Altman Z
4.81
Beneish M
−2.62
Dividend safety
82/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
27.08 57.84 16.52 37.69 57.39 50.55 39.49 35.52 45.87 41.40
Piotroski F-Score
7 5 3 5 3 8 6 7 6 5
P/S ratio
3.95 4.75 4.31 5.28 6.41 5.89 5.04 5.49 6.07 5.35
Altman Z-Score
4.26 4.56 3.85 4.31 3.90 4.54 4.18 4.76 5.30 4.81
Altman Z″-Score (non-manufacturers)
4.56 4.21 3.90 4.10 3.16 3.60 3.39 3.70 4.06 3.96
P/FCF ratio
31.35 61.45 28.77 50.92 32.98 36.82 45.70 35.86 39.34 31.36
Beneish M-Score
(2.34) (2.45) (2.28) (2.28) (2.72) (2.54) (2.32) (2.50) (2.57) (2.62)
P/Operating CF
67.90 86.97 56.06 106.83 74.38 100.82 92.77 73.59 71.04 62.68
Dividend Safety Score
— — — — — — — — — 82
P/B ratio
4.68 5.92 5.00 6.13 7.03 6.78 5.60 6.05 6.65 5.99
EV/Sales
4.26 5.10 4.76 5.72 7.18 6.45 5.65 5.97 6.47 5.82
EV/EBITDA
17.72 21.60 19.88 24.40 33.93 30.86 27.13 24.90 30.87 24.02
EV/FCF
33.83 66.06 31.80 55.24 36.91 40.28 51.16 39.03 41.95 34.11
Current Ratio
2.50 2.29 2.02 2.51 1.93 2.20 1.63 1.58 1.95 1.89
Net Debt/EBITDA
1.30 1.51 1.89 1.91 3.61 2.65 2.90 2.02 1.92 1.93
Debt/Equity
0.72 0.72 0.84 0.87 1.07 0.84 0.79 0.70 0.66 0.71
ROE
18.24% 10.45% 32.73% 16.98% 12.35% 14.26% 14.97% 17.98% 15.26% 15.08%
ROA
8.99% 4.79% 14.38% 7.26% 4.96% 5.78% 6.59% 8.24% 7.22% 7.15%
ROIC
10.39% 9.96% 8.86% 8.71% 5.78% 6.64% 6.40% 8.52% 7.75% 8.94%
Return on Tangible Assets
26.22% 15.73% 49.23% 22.58% 21.56% 24.02% 33.97% 40.51% 28.03% 29.95%
Average Days of Receivables
63.40 64.47 62.58 70.95 68.70 64.47 70.53 67.04 64.41 58.70
Earnings Yield
3.69% 1.73% 6.05% 2.65% 1.74% 1.98% 2.53% 2.82% 2.18% 2.42%
Free Cash Flow Yield
3.19% 1.63% 3.48% 1.96% 3.03% 2.72% 2.19% 2.79% 2.54% 3.19%
Free Cash Flow per Share
3.81 2.57 5.45 4.12 7.43 7.26 5.38 8.26 9.15 11.21
Book value per Share
25.53 26.68 31.36 34.24 34.84 39.46 43.93 48.98 54.16 58.66
Free Cash Flow
1,425.00 961.00 2,038.00 1,542.00 2,790.00 2,738.00 2,036.00 3,136.00 3,487.00 4,283.00
EV/EBIT
22.16 27.64 25.54 31.40 46.32 42.68 36.67 31.48 39.65 29.88
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026